MLLT1

MLLT1 super elongation complex subunit, the group of YEATS domain containing|Super elongation complex

Basic information

Region (hg38): 19:6210381-6279975

Links

ENSG00000130382NCBI:4298OMIM:159556HGNC:7134Uniprot:Q03111AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the MLLT1 gene.

  • not_specified (52 variants)
  • not_provided (2 variants)
  • Short_nose (1 variants)
  • Abnormal_cortical_gyration (1 variants)
  • Hypotonia (1 variants)
  • Cerebral_atrophy (1 variants)
  • Global_developmental_delay (1 variants)
  • Infantile_spasms (1 variants)
  • Hypertelorism (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the MLLT1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000005934.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
missense
1
clinvar
51
clinvar
1
clinvar
1
clinvar
54
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
0
Total 0 1 51 2 1

Highest pathogenic variant AF is 0.000048343132

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
MLLT1protein_codingprotein_codingENST00000252674 1266994
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9870.0133125669041256730.0000159
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.691973360.5870.00002253642
Missense in Polyphen3183.4070.37167790
Synonymous-0.4521571501.050.00001111073
Loss of Function3.94221.90.09149.26e-7311

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005700.0000544
Finnish0.000.00
European (Non-Finnish)0.00002700.0000264
Middle Eastern0.00005700.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. {ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948}.;
Disease
DISEASE: Note=A chromosomal aberration involving MLLT1 is associated with acute leukemias. Translocation t(11;19)(q23;p13.3) with KMT2A/MLL1. The result is a rogue activator protein.;
Pathway
Transcriptional misregulation in cancer - Homo sapiens (human);Gene expression (Transcription);RNA Polymerase II Pre-transcription Events;Formation of RNA Pol II elongation complex ;RNA Polymerase II Transcription;RNA Polymerase II Transcription Elongation (Consensus)

Recessive Scores

pRec
0.307

Intolerance Scores

loftool
0.0111
rvis_EVS
-0.62
rvis_percentile_EVS
17.31

Haploinsufficiency Scores

pHI
0.206
hipred
Y
hipred_score
0.825
ghis
0.586

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.991

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Mllt1
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; hematopoietic system phenotype; neoplasm; liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype;

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;negative regulation of protein kinase activity
Cellular component
fibrillar center;nucleus;nucleoplasm;cytosol;transcription elongation factor complex
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding